Boston Scientific (BSX) Long-Term Deferred Tax (2009 - 2026)

Boston Scientific has disclosed Long-Term Deferred Tax across 18 years of filings, most recently posting $3.9 billion for Q2 2026.

• In Q2 2026, Long-Term Deferred Tax rose 3.47% year-over-year to $3.9 billion; the TTM figure through Jun 2026 stood at $3.9 billion (up 3.47% YoY), while the FY2025 annual figure was $3.7 billion, up 0.55% from the prior year.
• Long-Term Deferred Tax came in at $3.9 billion for Q2 2026 at Boston Scientific, down from $4.0 billion in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $4.1 billion in Q1 2022 to a low of $3.7 billion in Q4 2024.
• Average Long-Term Deferred Tax over 5 years is $3.8 billion, with a median of $3.8 billion recorded in 2023.
• Year-over-year, Long-Term Deferred Tax dropped 4.92% in 2023 and climbed 7.54% in 2026.
• Over 5 years, Long-Term Deferred Tax stood at $3.9 billion in 2022, then retreated by 2.56% to $3.8 billion in 2023, then retreated by 4.84% to $3.7 billion in 2024, then rose by 0.55% to $3.7 billion in 2025, then climbed by 6.37% to $3.9 billion in 2026.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $3.9 billion in Q2 2026, $4.0 billion in Q1 2026, and $3.7 billion in Q4 2025.